Clinical trials
Phase 2 Sarcoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 8 |
| Active, not recruiting | 7 |
| Terminated | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Bergonié | 8 |
| Centre Oscar Lambret | 7 |
| UNICANCER | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Hoffmann-La Roche | 3 |
| Bayer | 2 |
| Centre Leon Berard | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Institut Claudius Regaud | 2 |
| AGC Biologics S.p.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 51 |
| Colorectal Neoplasms | 8 |
| Neoplasms | 7 |
| Leiomyosarcoma | 6 |
| Neoplasm Metastasis | 6 |
| Ovarian Neoplasms | 6 |
| Sarcoma, Synovial | 6 |
| Breast Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Hemangiosarcoma | 4 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.